Chief Accounting Officer
Monopar Therapeutics (MNPR)Equibles does not estimate personal net worth.
Get an email with a short summary when Monopar Therapeutics publishes a filing, an earnings call transcript or a press release.
Get MNPR alertsQuan Vu is recorded as Chief Accounting Officer at Monopar Therapeutics (MNPR) since March 3, 2025 and CFO at Monopar Therapeutics (MNPR). Monopar Therapeutics reported in an 8-K filed March 3, 2025 that Quan Vu was appointed principal financial officer, effective March 3, 2025. Monopar Therapeutics reported in an 8-K filed March 3, 2025 that Quan Vu was appointed Chief Financial Officer, effective March 3, 2025. Monopar Therapeutics reported in an 8-K filed March 3, 2025 that Quan Vu was appointed principal accounting officer, effective March 3, 2025. The proxy statement of Monopar Therapeutics reports total compensation of $2,101,314 for Quan Vu in fiscal 2025, including a base salary of $305,000. Disclosed compensation is on record for 2 fiscal years. Monopar Therapeutics is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Monopar Therapeutics includes Chandler D. Robinson (CEO and Board Member), Karthik Radhakrishnan (CFO and Chief Accounting Officer), Quan A. Vu (CFO) and 7 others.
“On February 27, 2025, the Company’s Board of Directors appointed Quan Vu, age 53, to succeed Mr. Radhakrishnan as Monopar’s Chief Financial Officer, principal accounting officer and principal financial officer effective March 3, 2025.”
“On February 27, 2025, the Company’s Board of Directors appointed Quan Vu, age 53, to succeed Mr. Radhakrishnan as Monopar’s Chief Financial Officer, principal accounting officer and principal financial officer effective March 3, 2025.”
2025-03-03–present
SEC 8-K
2025-03-03–present
MNPR
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2025-03-03–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Monopar Therapeutics (MNPR) | Chief Financial Officer, Secretary, and Treasurer | $305,000 | $2,101,314 |
| 2024 | Monopar Therapeutics (MNPR) | Chief Financial Officer, Secretary, and Treasurer | — | — |
